cRGD-Conjugated Fe₃O₄@PDA-DOX Multifunctional Nanocomposites for MRI and Antitumor Chemo-Photothermal Therapy

References

• Chen W, Zheng R, Badde PD. Cancer statistics in China. CA Cancer J Clin. 2015;2:115–132.
   Google Scholar
• Kuipers EJ, Grady WM, Lieberman D, et al. Colorectal cancer. Nat Rev Dis Primers. 2015;1:150–165. doi:10.1038/nrdp.2015.65
   Web of Science ®Google Scholar
• Modest DP, Pant S, Sartore-Bianchi A. Treatment sequencing in metastatic colorectal cancer. Eur J Cancer. 2019;109:70–83. doi:10.1016/j.ejca.2018.12.01930690295
   PubMed Web of Science ®Google Scholar
• Clifford R, Govindarajah N, Parsons JL, et al. Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer. Br J Surg. 2018;12:1553–1572. doi:10.1002/bjs.10993
   Google Scholar
• Cousins A, Thompson SK, Wedding AB, et al. Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging. Biotechnol Adv. 2014;32:269–279. doi:10.1016/j.biotechadv.2013.10.01124189095
   PubMedGoogle Scholar
• Kievit FM, Zhang MQ. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res. 2011;10:853–862. doi:10.1021/ar2000277
   Google Scholar
• Liu YJ, Bhattarai P, Dai ZF, et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2019;48(7):2053–2108.30259015
   PubMed Web of Science ®Google Scholar
• Beik YJ, Abed Z, Ghoreishi FS, et al. Nanotechnology in hyperthermia cancer therapy: from fundamental principles to advanced plications. J Control Release. 2016;235:205–221. doi:10.1016/j.jconrel.2016.05.06227264551
   PubMed Web of Science ®Google Scholar
• Zhu X, Feng W, Chang J, et al. Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature. Nat Commun. 2016;4:10437. doi:10.1038/ncomms10437
   Google Scholar
• Liu YX, Jia Q, Guo QW, et al. pH-activated heat shock protein inhibition and radical generation enhanced NIR luminescence imaging-guided photothermal tumour ablation. Int J Pharm. 2019;566:40–45. doi:10.3923/ijp.2019.40.4931129340
   PubMedGoogle Scholar
• Gai S, Yang G, Yang P, et al. Charge convertibility and near infrared photon co-enhanced cisplatin chemotherapy based on upconversion nanoplatform. Nano Today. 2017;130:42–45.
   Google Scholar
• Tahmasbi Rad A, Chen CW, Aresh WF, Xia Y, Lai PS, Nieh MP. Combinational effects of active targeting, shape, and enhanced permeability and retention for cancer theranostic nanocarriers. ACS Appl Mater Interfaces. 2019;11(11):10505–10519.30793580
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Drug Delivery Rev. 2014;66:22–25. doi:10.1016/j.addr.2013.11.009
   Web of Science ®Google Scholar
• Setyawati MI, Tay CY, Chia SL, et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin. Nat Commun. 2013;4:1673. doi:10.1038/ncomms265523575677
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387–6392.2946403
   PubMed Web of Science ®Google Scholar
• Riley RS, Day ES, Interdiscip W. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9:1449–1458. doi:10.1002/wnan.1449
   Web of Science ®Google Scholar
• Zeng JY, Zhang MK, Peng MY, et al. Porphyrinic metal–organic frameworks coated gold nanorods as a versatile nanoplatform for combined photodynamic/photothermal/chemotheory of tumor. Adv Funct Mater. 2018;20:1705451. doi:10.1002/adfm.201705451
   Google Scholar
• Guo Z, Zhu S, Yong Y, et al. Synthesis of BSA-coated BiOI@Bi2 S3 semiconductor heterojunction nanoparticles and their applications for radio/photodynamic/photothermal synergistic therapy of tumor. Adv Mater. 2017;20:1704136. doi:10.1002/adma.201704136
   Google Scholar
• Xing Y, Zhang J, Chen F, et al. Mesoporous polydopamine nanoparticles with co-delivery function for overcoming multidrug resistance via synergistic chemo-photothermal therapy. Nanoscale. 2017;9:8781–8790. doi:10.1039/C7NR01857F28621774
   PubMed Web of Science ®Google Scholar
• Xu X, Wang J, Wang Y, et al. Formation of graphene oxide-hybridized nanogels for combinative anticancer therapy. Nanomedicine. 2018;14:2387–2395. doi:10.1016/j.nano.2017.05.00728552643
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhi X, Yang M, et al. Tumor-triggered drug release from calcium carbonate-encapsulated gold nanostars for near-infrared photodynamic/photothermal combination antitumor therapy. Theranostics. 2017;7:1650–1662. doi:10.7150/thno.1760228529642
   PubMed Web of Science ®Google Scholar
• Goodman AM, Neumann O, Norregaard K, Henderson L. Near-infrared remotely triggered drug-release strategies for cancer treatment. Acad Sci U S A. 2017;114:12419–12424. doi:10.1073/pnas.1713137114
   PubMed Web of Science ®Google Scholar
• Liu Y, Jia Q, Guo Q, et al. Simultaneously activating highly selective ratiometric MRI and synergistic therapy in response to intratumoral oxidability and acidity. Biomaterials. 2018;180:104–116. doi:10.1016/j.biomaterials.2018.07.02530032045
   PubMed Web of Science ®Google Scholar
• Chu M, Shao Y, Peng J. Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles. Biomaterials. 2013;16:4078–4088. doi:10.1016/j.biomaterials.2013.01.086
   Google Scholar
• Ao L, Wu C, Liu K. Polydopamine derivated hierarchical nanoplatform for efficient dual-modal imaging guided combination in vivo cancer therapy. ACS Appl Mater Interfaces. 2018;10:12544–12552. doi:10.1021/acsami.8b0297329569431
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang J, Wang Y. Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation. Biomaterials. 2015;81:114–124. doi:10.1016/j.biomaterials.2015.11.03726731575
   PubMedGoogle Scholar
• Liu YX, Guo QW, Zhu XJ, et al. Optimization of prussian blue coated NaDyF4: x%Lu nanocomposites for multifunctional imaging-guided photothermal therapy. Adv Funct Mater. 2016;26:5120–5130. doi:10.1002/adfm.v26.28
   Web of Science ®Google Scholar
• Harisinghani MG, Barentsz J, Hahn PF. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2013;348:2491–2499. doi:10.1056/NEJMoa022749
   Google Scholar
• Heilmaier C, Lutz AM, Bolog N, et al. Focal liver lesions: detection and characterization at double-contrast liver MR imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Radiology. 2019;253:724–733. doi:10.1148/radiol.2533090161
   Google Scholar
• Seeney CE. The emerging applications of magnetic nanovectors in nanomedicine. Pharm Pat Anal. 2015;4:285–304. doi:10.4155/ppa.15.1726174567
   PubMedGoogle Scholar
• Heilmaier C, Ruiz A, Gutiérrez L, et al. Biotransformation of magnetic nanoparticles as a function of coating in a rat model. Nanoscale. 2015;7:16321–16329. doi:10.1039/C5NR03780H26381991
   PubMedGoogle Scholar
• Kolosnjaj-Tabi J, Lartigue L, Javed Y, et al. Biotransformations of magnetic nanoparticles in the body. Nano Today. 2016;11:280–284. doi:10.1016/j.nantod.2015.10.001
   Web of Science ®Google Scholar
• Liu Y, Ai K, Liu J, et al. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy. Adv Mater. 2013;25:1353–1359. doi:10.1002/adma.v25.923280690
   PubMed Web of Science ®Google Scholar
• Hak-Sung J, Kyung-Jin C, Yeonee S. Polydopamine encapsulation of fluorescent nanodiamonds for biomedical applications. Adv Funct Mater. 2018;28:1801252. doi:10.1002/adfm.20180125230686957
   PubMedGoogle Scholar
• Barandov A, Bartelle BB, Gonzalez BA, et al. Membrane-permeble Mn(III) complexes for molecular magnetic resonance imaging of intracellular targets. J Am Chem Soc. 2016;138:5483–5486. doi:10.1021/jacs.5b1333727088782
   PubMed Web of Science ®Google Scholar
• Teo PY, Cheng W, Hedrick JL, et al. Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug Deliv Rev. 2016;98:41–63. doi:10.1016/j.addr.2015.10.01426529199
   PubMed Web of Science ®Google Scholar
• Zheng R, Wang S, Tian Y, et al. Polydopamine-coated magnetic composite particles with enhanced photothermal effect. CS Appl Mater Interfaces. 2015;7:15876–15884. doi:10.1021/acsami.5b03201
   PubMed Web of Science ®Google Scholar
• Cao L, Du P, Jiang S, et al. Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature. Mol Cancer Ther. 2008;7:851–861. doi:10.1158/1535-7163.MCT-07-053318413798
   PubMed Web of Science ®Google Scholar
• Zhi S, Lin Y, Zhang X, et al. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects. Int J Nanomedicine. 2017;12:1941–1958. doi:10.2147/IJN.S12557328331317
   PubMedGoogle Scholar
• Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology. 1995;13:265–270. doi:10.1038/nbt0395-2659634769
   PubMedGoogle Scholar
• Assa-Munt N 1, Jia X, Laakkonen P, et al. Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry. 2001;40:2373–2378. doi:10.1021/bi002101f11327857
   PubMed Web of Science ®Google Scholar
• Burkhart DJ, Kalet BT, Coleman MP. Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin. Mol Cancer Ther. 2004;3:1593–1604.15634653
   PubMed Web of Science ®Google Scholar
• Kolhar P, Kotamraju VR, Hikita ST, et al. Synthetic surfaces for human embryonic stem cell culture. J Biotechnol. 2010;146:143–146. doi:10.1016/j.jbiotec.2010.01.01620132848
   PubMedGoogle Scholar